Biosafety data as confidential business information.
Removal of confidentiality claims on biosafety data is necessary to adhere to standard scientific procedures of quality assurance, to increase transparency, to minimize impacts of conflicts of interests, and ultimately to improve public confidence in GMOs.
Saved in:
Main Author: | Kaare M Nielsen |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2013
|
Subjects: | |
Online Access: | https://doaj.org/article/94e9c705bfe74588872bd00c8d05debe |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biosafety Guidelines for Handling Microorganisms in the Teaching Laboratory: Development and Rationale
by: Elizabeth A. B. Emmert
Published: (2013) -
Dealing with data: a case study on information and data management literacy.
by: Melissa A Haendel, et al.
Published: (2012) -
Biosafety Level-4 laboratories in Europe: opportunities for public health, diagnostics, and research.
by: Carla Nisii, et al.
Published: (2013) -
Guidelines for Biosafety in Teaching Laboratories Version 2.0: A Revised and Updated Manual for 2019
by: Jeffrey J. Byrd, et al.
Published: (2019) -
Synergistic stabilization of a double mutant in chymotrypsin inhibitor 2 from a library screen in E. coli
by: Louise Hamborg, et al.
Published: (2021)